Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification

Na Yang, Shun Feng, Kerby Shedden, Xiaolei Xie, Yashu Liu, Charles J. Rosser, David M. Lubman, Steven Goodison

Research output: Contribution to journalArticle

88 Scopus citations

Abstract

Background: Cancers of the urinary bladder are the fifth most commonly diagnosed malignancy in the United States. Early clinical diagnosis of bladder cancer remains a major challenge, and the development of noninvasive methods for detection and surveillance is desirable for both patients and health care providers. Approach: To identify urinary proteins with potential clinical utility, we enriched and profiled the glycoprotein component of urine samples by using a dual-lectin affinity chromatography and liquid chromatography/tandem mass spectrometry platform. Results: From a primary sample set obtained from 54 cancer patients and 46 controls, a total of 265 distinct glycoproteins were identified with high confidence, and changes in glycoprotein abundance between groups were quantified by a label-free spectral counting method. Validation of candidate biomarker alpha-1-antitrypsin (A1AT) for disease association was done on an independent set of 70 samples (35 cancer cases) by using an ELISA. Increased levels of urinary A1AT glycoprotein were indicative of the presence of bladder cancer (P < 0.0001) and augmented voided urine cytology results. A1AT detection classified bladder cancer patients with a sensitivity of 74% and specificity of 80%. Summary: The described strategy can enable higher resolution profiling of the proteome in biological fluids by reducing complexity. Application of glycoprotein enrichment provided novel candidates for further investigation as biomarkers for the noninvasive detection of bladder cancer.

Original languageEnglish (US)
Pages (from-to)3349-3359
Number of pages11
JournalClinical Cancer Research
Volume17
Issue number10
DOIs
StatePublished - May 15 2011

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification'. Together they form a unique fingerprint.

  • Cite this